LAX.SH
P&G HYGIENE & HEALTH CARE·FMCG 49.13·Personal Products Companies
Price
8,892
-0.09%52W Range
Market Cap
₹28,864.09 Cr
Traded: ₹4.76 Cr (0.02%) 0.0x
Free Float: ₹3,587.81 Cr (0.13% of FF traded)
Volume · 60D trend
5.35 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +6.0% | +7.0% | +3.0% | -- | +27.0% | Stable |
| ROE | +60.0% | +83.0% | +89.0% | -- | -- | Accelerating |
| Return | +4.0% | -6.0% | -12.0% | -30.0% | -- | Decelerating |
| Profit | +9.0% | +15.0% | +14.0% | -- | +35.0% | Stable |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 941 | 1,262 | 1,150 | 937 | 992 | 1,248 | 1,135 | 932 | 1,002 | 1,133 | 1,138 | 853 | 883 |
| Expenses | 723 | 860 | 865 | 671 | 782 | 877 | 845 | 813 | 745 | 824 | 853 | 638 | 734 |
| Operating Profit | 218 | 402 | 285 | 266 | 210 | 371 | 290 | 118 | 257 | 310 | 285 | 215 | 149 |
| OPM % | 23.0% | 32.0% | 25.0% | 28.0% | 21.0% | 30.0% | 26.0% | 13.0% | 26.0% | 27.0% | 25.0% | 25.0% | 17.0% |
| Other Income | 12 | 12 | 10 | 8 | 19 | 10 | 8 | 7 | 14 | 16 | 16 | 10 | 14 |
| Interest | 3 | 3 | 4 | 0 | 6 | 7 | 2 | 0 | 22 | 3 | 2 | 3 | 4 |
| Depreciation | 10 | 10 | 9 | 9 | 10 | 10 | 12 | 13 | 15 | 14 | 14 | 15 | 15 |
| Profit Before Tax | 218 | 402 | 282 | 265 | 213 | 364 | 285 | 112 | 234 | 309 | 284 | 207 | 146 |
| Tax % | 30.0% | 25.0% | 26.0% | 27.0% | 27.0% | 26.0% | 26.0% | 28.0% | 34.0% | 26.0% | 26.0% | 27.0% | -13.0% |
| Net Profit | 153 | 301 | 210 | 192 | 156 | 269 | 212 | 81 | 154 | 229 | 211 | 151 | 165 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 47.2 | 92.9 | 64.7 | 59.2 | 48.1 | 82.7 | 65.3 | 25.0 | 47.6 | 70.5 | 64.9 | 46.6 | 50.8 |
| Sales Growth (YoY) | -5.1% | 1.1% | 1.3% | 0.5% | -1.0% | 10.2% | -0.3% | 9.3% | 13.5% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -25.4% | 9.7% | 22.7% | -5.5% | -20.5% | 10.0% | 21.8% | -7.0% | -11.6% | -0.4% | 33.4% | -3.4% | -- |
| OP Growth (YoY) | 3.8% | 8.4% | -1.7% | 125.4% | -18.3% | 19.7% | 1.8% | -45.1% | 72.5% | -- | -- | -- | -- |
| OP Growth (QoQ) | -45.8% | 41.1% | 7.1% | 26.7% | -43.4% | 27.9% | 145.8% | -54.1% | -17.1% | 8.8% | 32.6% | 44.3% | -- |
| Profit Growth (YoY) | -2.0% | 12.0% | -1.0% | 137.0% | 1.0% | 17.0% | 1.0% | -46.0% | -6.0% | 10.0% | 36.0% | 255.0% | 60.0% |
| EPS Growth (YoY) | -1.9% | 12.2% | -1.0% | 137.0% | 1.1% | 17.3% | 0.6% | -46.4% | -6.5% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -49.2% | 43.6% | 9.3% | 23.0% | -41.9% | 26.8% | 161.4% | -47.5% | -32.6% | 8.6% | 39.3% | -8.4% | -- |
| OP Margin | 23.2% | 31.9% | 24.8% | 28.4% | 21.2% | 29.7% | 25.6% | 12.7% | 25.6% | 27.4% | 25.0% | 25.2% | 16.9% |
| Net Margin | 16.3% | 23.9% | 18.3% | 20.5% | 15.7% | 21.6% | 18.7% | 8.7% | 15.4% | 20.2% | 18.5% | 17.7% | 18.7% |
| Material Cost % | 37.9% | 33.4% | 38.7% | 36.4% | 39.8% | 35.2% | 37.1% | 40.8% | 33.7% | 39.8% | 39.1% | 42.2% | 43.5% |
| Employee Cost % | 6.0% | 4.9% | 4.2% | 5.2% | 5.0% | 5.3% | 5.3% | 7.2% | 6.0% | 4.8% | 5.6% | 5.6% | 5.6% |
| P/S | 6.73 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 33.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 38.33 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50The Company has informed the Exchange regarding Change in Senior Management Personnel
The Company has informed the Exchange regarding Closure of Trading Window for the quarter ended June 30, 2026
Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the ....
Communication in respect of TDS on Final Dividend for the FY 2025-26
Please find enclosed letter as sought from the Company regarding Volume Movement across Exchanges
Please find enclosed disclosure under Regulation 7(2) of the SEBI (PIT) Regulations, 2015
The Exchange has sought clarification from Procter & Gamble Hygiene and Health Care Ltd on June 19, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.
The Company has informed the Exchange regarding Presentation of the analysts/ institutional investors meet scheduled to be held today
Dear Sir, Please find attached transcript and link to the recording of the analyst/institutional shareholders meeting held earlier today.
The Company has informed the Exchange about change in Senior Management Personnel
Dear Sir, Please find the attached intimation for the change in Directors and KMP of the Company.
We are enclosing herewith the following: Audited Financial Results for the Financial Year ended March 31, 2026, as per format prescribed under Regulation 33 of Securities Exchange Board ....
Please find the attached press release for the quarter ended March 31, 2026.
Board has recommended the Final Dividend for the Financial Year ended March 31, 2026, subject to the approval of shareholders
Dear Sir, Please find the attached Financial Results for the financial year ended March 31, 2026
Dear Sir, Board has fixed the Record Date for the purpose of Dividend and AGM.
Dear Sir, Please find the attached resignation of Chief Financial Officer of the Company.
The Company has submitted Certificate under regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026
The Company has informed the Exchange regarding the update on Special Window for Transfer and Dematerialization of Physical Securities
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
The Company has informed the Exchange regarding closure of trading window for the quarter ending March 31, 2026
Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Audited ....
The Company has informed the Exchange regarding the change in Senior Management Personnel
The Company has informed the Exchange that Mr. Ghanashyam Hegde, Legal Head, Executive Director and Company Secretary of the Company will be moving to a regional role in P&G as Vice President ....
The Company has informed the Exchange that Mr. Ghanashyam Hegde, Legal Head, Executive Director and Company Secretary of the Company will be moving to a regional role in P&G as Vice President ....
The Company has informed the Exchange that Mr. Ghanashyam Hegde will be moving to a regional role in P&G as Vice President & Associate General Counsel - Market Operations, India, Middle ....
Company has fixed record date as February 5, 2026, for the purpose of eligibility of payment of interim dividend declared at the board meeting held on January 30, 2026.
Dear Sir, We are pleased to inform that the Company has declared interim dividend of Rs. 195 per share (including special dividend of Rs. 25 per share) for the financial year 2025-26.
Communication in respect of TDS on Interim Dividend for the FY 2025-26
Please find attached press release for the quarter ended December 31, 2025.
We are pleased to inform you that at a meeting of the Board of Directors of the Company held today (commenced at 12:54 P.M. and ended at 01:57 P.M.), the Unaudited Financial Results for ....
Dear Sir, Please find enclosed the Financial Results for the quarter ended December 31, 2025
Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve The ....
The Company has submitted Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2025
Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve Unaudited ....
The Company has informed the Exchange about the closure of trading window for the quarter ending December 31, 2025
Change in Senior Management Personnel of the Company
Dear Sir/Madam, Please be informed regarding change in senior management personnel of our Company, as detailed in enclosed letter.
Press Release on Unaudited Financial Results for the quarter ended September 30, 2025
Financial Results for the quarter ended September 30, 2025
Dear Sir, Please find attached Outcome of Board Meeting held on November 6, 2025
Dear Sir, Please find attached certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2025
Purpose of the meeting has been revised
Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider and approve Intimation ....
Intimation for closure of trading window
Intimation regarding re-appointment of Mr. Chittranjan Dua as Independent Director of the Company
Dear Sir, Please find attached intimation regarding re-appointment of Mr. Krishnamurthy Iyer as Independent Director of the Company.
Dear Sir, Please find attached proceedings of the AGM held on September 4, 2025
Please find attached voting results of the resolutions passed at the AGM on September 4, 2025.
Re-submission of annual report under regulation 34(1) of SEBI LODR Regulations, 2015
Annual Reports
15Concalls
4Jun 2025
30 Jun 2025Sep 2024
30 Sept 2024Sep 2023
30 Sept 2023Mar 2019
31 Mar 2019Held by ETFs
4 ETFs hold PGHH · sorted by weight
Held by Mutual Funds
5 schemes hold PGHH · sorted by weight